Market Closed -
Toronto S.E.
01:30:00 18/06/2024 am IST
|
5-day change
|
1st Jan Change
|
4.19
CAD
|
-0.24%
|
|
+0.72%
|
+8.83%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
179.6
|
1,307
|
1,022
|
653.6
|
929.5
|
1,031
|
-
|
-
|
Enterprise Value (EV)
1 |
168.7
|
1,307
|
1,297
|
898
|
1,231
|
1,310
|
1,296
|
1,196
|
P/E ratio
|
-19.5
x
|
-268
x
|
-21.3
x
|
-
|
-
|
2,106
x
|
-224
x
|
41.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.48
x
|
26
x
|
3.38
x
|
1.15
x
|
1.2
x
|
1.06
x
|
0.97
x
|
0.94
x
|
EV / Revenue
|
5.14
x
|
26
x
|
4.29
x
|
1.58
x
|
1.59
x
|
1.35
x
|
1.22
x
|
1.09
x
|
EV / EBITDA
|
-98.5
x
|
-14,209
x
|
21.5
x
|
8.59
x
|
10.9
x
|
10.3
x
|
8.59
x
|
7.59
x
|
EV / FCF
|
-
|
-201
x
|
66.2
x
|
12.8
x
|
21.1
x
|
20.2
x
|
15.8
x
|
15.8
x
|
FCF Yield
|
-
|
-0.5%
|
1.51%
|
7.81%
|
4.74%
|
4.94%
|
6.31%
|
6.34%
|
Price to Book
|
0.05
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,15,159
|
1,62,404
|
2,08,166
|
2,30,153
|
2,41,428
|
2,46,080
|
-
|
-
|
Reference price
2 |
1.560
|
8.050
|
4.910
|
2.840
|
3.850
|
4.190
|
4.190
|
4.190
|
Announcement Date
|
31/03/20
|
18/03/21
|
31/03/22
|
21/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
32.81
|
50.24
|
302.3
|
569.1
|
776.1
|
969.4
|
1,062
|
1,094
|
EBITDA
1 |
-1.713
|
-0.092
|
60.36
|
104.6
|
113.4
|
127.6
|
150.8
|
157.7
|
EBIT
1 |
-6.086
|
-10.41
|
-12.79
|
23.31
|
35.16
|
52.44
|
86.49
|
122.2
|
Operating Margin
|
-18.55%
|
-20.71%
|
-4.23%
|
4.1%
|
4.53%
|
5.41%
|
8.14%
|
11.17%
|
Earnings before Tax (EBT)
1 |
-7.759
|
-6.986
|
-24.97
|
17.92
|
19.5
|
22.54
|
47.63
|
81.7
|
Net income
1 |
-7.819
|
-3.686
|
-43.79
|
1.369
|
0.082
|
1.184
|
5.773
|
25
|
Net margin
|
-23.83%
|
-7.34%
|
-14.48%
|
0.24%
|
0.01%
|
0.12%
|
0.54%
|
2.28%
|
EPS
2 |
-0.0800
|
-0.0300
|
-0.2300
|
-
|
-
|
0.001990
|
-0.0187
|
0.1000
|
Free Cash Flow
1 |
-
|
-6.517
|
19.59
|
70.14
|
58.33
|
64.78
|
81.81
|
75.8
|
FCF margin
|
-
|
-12.97%
|
6.48%
|
12.32%
|
7.52%
|
6.68%
|
7.7%
|
6.93%
|
FCF Conversion (EBITDA)
|
-
|
-
|
32.45%
|
67.08%
|
51.44%
|
50.79%
|
54.24%
|
48.07%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
5,123.59%
|
71,134.15%
|
5,473.88%
|
1,417.08%
|
303.2%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/03/20
|
18/03/21
|
31/03/22
|
21/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
115.7
|
126.5
|
140.3
|
145.8
|
156.5
|
169.4
|
170.9
|
204.5
|
231.2
|
231.6
|
236
|
244.7
|
257.6
|
254.6
|
259.1
|
EBITDA
1 |
25.68
|
23.49
|
26.43
|
27.46
|
27.17
|
26.68
|
27.79
|
28.17
|
30.75
|
28.31
|
29.63
|
33.07
|
36.46
|
34.39
|
34.87
|
EBIT
1 |
6.848
|
7.374
|
6.324
|
8.578
|
2.288
|
8.759
|
10.11
|
7.079
|
9.209
|
8.853
|
10.76
|
14.81
|
18.52
|
18.18
|
19.14
|
Operating Margin
|
5.92%
|
5.83%
|
4.51%
|
5.88%
|
1.46%
|
5.17%
|
5.91%
|
3.46%
|
3.98%
|
3.82%
|
4.56%
|
6.05%
|
7.19%
|
7.14%
|
7.39%
|
Earnings before Tax (EBT)
1 |
2.287
|
-0.039
|
-3.025
|
3.785
|
18.36
|
-10.44
|
-0.127
|
-4.507
|
34.57
|
19.42
|
0.0617
|
2.504
|
8.638
|
9.5
|
10.5
|
Net income
1 |
-8.803
|
-8.019
|
-5.903
|
-4.419
|
20.63
|
-14.36
|
-5.767
|
-7.606
|
27.81
|
15.09
|
-3.431
|
-1.251
|
1.864
|
4.974
|
5.627
|
Net margin
|
-7.61%
|
-6.34%
|
-4.21%
|
-3.03%
|
13.18%
|
-8.47%
|
-3.37%
|
-3.72%
|
12.03%
|
6.52%
|
-1.45%
|
-0.51%
|
0.72%
|
1.95%
|
2.17%
|
EPS
2 |
-0.0400
|
-0.0400
|
-0.0300
|
-0.0200
|
0.0900
|
-0.0600
|
-0.0300
|
-0.0300
|
0.1200
|
0.0600
|
-0.0100
|
-
|
0.0133
|
0.0100
|
0.0100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/03/22
|
11/05/22
|
11/08/22
|
10/11/22
|
21/03/23
|
12/05/23
|
10/08/23
|
14/11/23
|
21/03/24
|
08/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
275
|
244
|
302
|
279
|
264
|
165
|
Net Cash position
1 |
10.9
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
4.549
x
|
2.337
x
|
2.66
x
|
2.188
x
|
1.753
x
|
1.049
x
|
Free Cash Flow
1 |
-
|
-6.52
|
19.6
|
70.1
|
58.3
|
64.8
|
81.8
|
75.8
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
33.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-0.0300
|
-0.0400
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.47
|
1.13
|
2.68
|
6.4
|
8.11
|
7.77
|
8.38
|
9.2
|
Capex / Sales
|
1.44%
|
2.26%
|
0.89%
|
1.13%
|
1.04%
|
0.8%
|
0.79%
|
0.84%
|
Announcement Date
|
31/03/20
|
18/03/21
|
31/03/22
|
21/03/23
|
21/03/24
|
-
|
-
|
-
|
Last Close Price
4.19
CAD Average target price
7.375
CAD Spread / Average Target +76.01% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.83% | 750M | | +23.94% | 87.86B | | -22.63% | 76.69B | | +3.24% | 26.86B | | +3.95% | 17.76B | | -11.32% | 16.99B | | -0.62% | 15.22B | | +76.28% | 13.56B | | +81.13% | 13.37B | | -24.56% | 13.01B |
Other Healthcare Facilities & Services
|